title: [Clinical study of irinotecan therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer].
authors.affiliation: Dept. of Internal Medicine, National Hospital Organization Shikoku Cancer Center.
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Nishina
authors.forename: Ichinosuke
authors.initials: I
authors.lastname: Hyodo
authors.forename: Toshikazu
authors.initials: T
authors.lastname: Moriwaki
authors.forename: Takeshi
authors.initials: T
authors.lastname: Kajiwara
authors.forename: Takao
authors.initials: T
authors.lastname: Tsuzuki
authors.forename: Ken
authors.initials: K
authors.lastname: Hirao
authors.forename: Eiji
authors.initials: E
authors.lastname: Tubouchi
authors.forename: Junichirou
authors.initials: J
authors.lastname: Nasu
authors.forename: Shoji
authors.initials: S
authors.lastname: Hirasaki
authors.forename: Toshikazu
authors.initials: T
authors.lastname: Masumoto
authors.forename: Yoshiro
authors.initials: Y
authors.lastname: Kubo
authors.forename: Akira
authors.initials: A
authors.lastname: Kurita
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D000077146:Irinotecan; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage; D011743:Pyrimidines / Q000494:pharmacology; D012189:Retrospective Studies; D015996:Survival Rate
chemical_list: D011743:Pyrimidines; D016685:Mitomycin; D000077146:Irinotecan; D002166:Camptothecin